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Background and purpose: Invasive nontyphoidal salmonellosis, mostly caused by serovars 
Typhimurium and Enteritidis of Salmonella enterica, has emerged as a major public health 
problem in sub-Saharan Africa. The aim of this study was the clinical and microbiological char-
acterization of nontyphoidal salmonellosis episodes affecting febrile children in Mozambique.
Patients and methods: The clinical records of the patients were evaluated, and S. enterica 
isolates were characterized with regard to serovar, phage type, antimicrobial resistance (phe-
notype/responsible genes), plasmid content, pulsed-field gel electrophoresis, and multilocus 
sequence typing.
Results: Fifteen S. Typhimurium and 21 S. Enteritidis isolates were recovered from blood 
samples of 25 children, the majority with underlying risk factors. With regard to phage typing, 
most isolates were either untypeable or reacted but did not conform, revealing that a number of 
previously unrecognized patterns are circulating in Mozambique. Most isolates were multidrug-
resistant, with nearly all of the responsible genes located on derivatives of serovar-specific 
virulence plasmids. ST313 and ST11 were the predominant sequence types associated with 
S. Typhimurium and S. Enteritidis, respectively, and the uncommon ST1479 was also detected 
in S. Enteritidis. A distinct XbaI fragment of ~350 kb was associated with pulsed-field gel elec-
trophoresis patterns of multidrug-resistant isolates of S. Enteritidis. Nearly half of the children 
were coinfected with both serovars, a fact expected to aggravate the disease and hamper the 
treatment. However, particularly poor outcomes were not observed for the coinfected patients.
Conclusion: Mixed Salmonella infections could frequently occur in febrile children in Mozam-
bique. Additional studies are required to determine their actual impact and consequences, not 
only in this country, but also in other African countries.
Keywords: invasive nontyphoidal salmonellosis, bloodstream infection, multidrug resistance, 
virulence-resistance plasmid, ST313, ST1479
Introduction
Nontyphoidal serovars of Salmonella enterica are a prominent cause of bloodstream 
infections in sub-Saharan Africa, which mainly affect children with specific risk fac-
tors, including malnutrition, severe anemia, malaria, and HIV infection, as well as 
HIV-infected or immunocompromised adults.1–3 S. Typhimurium and S. Enteritidis are 
the most common serovars involved in invasive nontyphoidal salmonellosis (iNTS).4–6 
Phylogenetic analysis based on single-nucleotide polymorphisms revealed that the 
majority of the invasive S. Typhimurium from sub-Saharan countries belong to sequence 
type (ST) 313 and are distributed into two closely related lineages designated I and 
II.7,8 Both lineages comprise multidrug-resistant (MDR) isolates carrying distinct 
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derivatives of pSLT, the ~94 kb virulence plasmid specific 
of S. Typhimurium, where multiple resistance genes are 
located.7,8 Examples of such plasmids are pSLT-A130 (con-
ferring resistance to ampicillin, kanamycin, sulfonamides, 
and trimethoprim), carried by the A130 isolate representa-
tive of lineage I, and pSLT-BT (responsible for resistance 
to ampicillin, chloramphenicol, kanamycin, streptomycin, 
sulfonamides, and trimethoprim), found in D23580 of lineage 
II. With regard to S. Enteritidis, it is of note that MDR isolates 
of this serovar were recovered in the UK from blood and feces 
of patients who had an African name or had recently traveled 
to Africa.9 The UK isolates were phage type (PT) 42 and 
belonged to ST11, the most common ST in S. Enteritidis, or 
to the infrequent ST1479. MDR in these isolates was encoded 
by derivatives of pSEV, the ~60 kb virulence plasmid of S. 
Enteritidis, related to pUO-SeVR1, a plasmid first detected 
in a PT14b, ST11 isolate collected in Spain from feces of a 
young child with gastroenteritis.10 Recently, whole genome 
sequence analysis of S. Enteritidis from sub-Saharan Africa 
identified two related but phylogenetically and geographically 
distinct clades, the Western African clade and the Central/
Eastern African clade. In both clades, MDR was encoded by 
pSEV derivatives highly similar to pUO-SeVR1.11
In rural Mozambique, previous studies revealed that non-
typhoidal Salmonella is the most frequent cause of bacteremia 
in children younger than 15 years admitted to the Manhiça 
District Hospital (MDH).5,12,13 Like in other African countries, 
S. Typhimurium and S. Enteritidis were the most frequent 
serovars, accounting for 66% and 25% of the cases, respec-
tively.13 To broad our knowledge on iNTS in Mozambique, 
the present study focused on a number of isolates causing 
bacteremia in children, which were characterized with regard 
to serovar, PT, resistance properties (including phenotypes, 
genes, integrons, and plasmids involved), and genomic types 
established by pulsed-field gel electrophoresis (PFGE) and 
multilocus sequence typing (MLST). The study disclosed a 
relatively high number of mixed infections with the simulta-
neous detection of S. Typhimurium and S. Enteritidis isolates 
in a single episode of bacteremia.
Material and methods
Setting, patients, and bacterial isolates
Twenty-five blood samples positive for Salmonella were 
recovered during the period 2002–2004 from different 
children admitted to the MDH (the referral health facility 
for a rural area located in Southern Mozambique), and the 
clinical histories of the patients were retrospectively revised. 
The identification of Salmonella was based on Gram  staining 
and biochemical methods.14 Serotyping was performed at 
the Centro de Investigação em Saúde da Manhiça (CISM, 
Maputo, Moçambique) by traditional slide agglutination with 
commercially available antisera (polyvalent and monoclonal; 
Bio-Rad, Marnes-la-Coquette, France) and by a PCR-based 
method.15 Serotyping results were confirmed at the Centro 
Nacional de Microbiología (CNM, Madrid, Spain), where 
PTs were also determined. Isolates showing a pattern that did 
not conform to previously recognized PTs were designated 
as “reacted but did not conform” (RDNC). Isolates that did 
not react with any of the typing phages were designated as 
“untypeable” (UT).
Antimicrobial susceptibility testing and 
detection of resistance genes
Susceptibility to ampicillin, chloramphenicol, ciprofloxacin, 
cefotaxime, cefoxitin, cephalothin, gentamicin, kanamycin, 
nalidixic acid, sulfonamides, nitrofurantoin, streptomycin, 
tetracycline, and trimethoprim was tested by the disc diffusion 
method on Mueller–Hinton agar, using commercially avail-
able discs (Oxoid, Madrid, Spain). Results were interpreted 
according to the guidelines of the Clinical and Laboratory 
Standards Institute.16
Genes responsible for resistance to ampicillin (bla
OXA-1-like
, 
bla
PSE-1
, and bla
TEM-1-like
), chloramphenicol (catA1, catA2, 
cmlA1-like, and floR), gentamicin/kanamycin [aac(3)-II, 
aac(3)-IV, and aadB], streptomycin (aadA1-like, aadA2, strA, 
and strB), sulfonamides (sul1, sul2, and sul3), tetracycline 
[tet(A), tet(B), and tet(G)], and trimethoprim (dfrA1-like, 
dfrA7-dfrA17, and dfrA12) were screened by PCR amplifica-
tion using previously described primers and conditions,17–19 
except for catA2 (catA2-F/R: 5’-AGCTTACGGAGGAC-
GGAATG-3’/5’-CACCAATCCTGCCGGATACG-3’). The 
genetic bases of nalidixic acid resistance were investigated 
by using PCR amplification and sequencing of the quinolone 
resistance-determining region of the gyrA gene.20 The pres-
ence of class 1 and 2 integrons was investigated by using the 
5’-CS/3’-CS and Hep74/Hep51 primers, and gene cassettes 
located therein were identified by nested PCR amplification 
with primers selected according to the detected resistance 
genes.21,22 Gene cassettes were sequenced at Macrogen 
Europe (Amsterdam, The Netherlands), when required for 
allele identification.
Plasmid analysis, conjugation, and 
transformation experiments
Plasmid DNA was extracted by using an alkaline lysis 
method.23 Electrophoresis was carried out on 0.6% agarose 
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gels for 3–4 hours at 100 V. Plasmids obtained from Esch-
erichia coli V517 (54, 7.3, 5.6, 5.1, 3.9, 3, 2.7, and 2.1 kb), 
E. coli 39R861 (150, 65, 37, and 7 kb), S. Typhimurium ATCC 
14028 (pSLT; 94 kb), S. Enteritidis ATCC 13076 (pSEV; 60 
kb), and S. Enteritidis CNM 4839/03 (which contains two 
plasmids, pUO-SeVR1 of 110 kb and a cryptic plasmid of 
~80 kb) were used as size standards.
All isolates were screened for the IncFIIA and IncFIB 
replicons and the spvC gene of serovar-specific virulence 
plasmids, by PCR amplification using previously described 
primers and conditions.10,24 pSLT and pSEV were included 
as positive controls. Isolates harboring small plasmids were 
also tested for the ColE replicon.25
Triparental conjugation experiments were performed on 
Luria–Bertani liquid medium at 37°C for 20 hours using the 
invasive S. Typhimurium and S. Enteritidis isolates as donors, 
a derivative of E. coli K12 J53 resistant to rifampicin as the 
recipient, and E. coli MT1694, resistant to kanamycin and 
containing the conjugative pRK2013 plasmid, as a helper 
strain. Transconjugants were selected on Eosin Methylene 
Blue agar (Oxoid) supplemented with rifampicin (50 mg/L) 
plus either ampicillin (100 mg/L), chloramphenicol (30 mg/L), 
streptomycin (30 mg/L), sulfonamides (300 mg/L), tetracycline 
(30 mg/L), or trimethoprim (10 mg/L). For transformation 
experiments, plasmid DNA obtained from selected isolates 
was purified by the High Pure Plasmid Isolation Kit (Roche, 
Madrid, Spain) and transformed into a nalidixic acid-resistant 
derivative of E. coli DH5α. The preparation of competent 
cells and transformation were as in Sambrook and Russell.26 
Transformants were selected in Luria–Bertani agar medium 
supplemented with nalidixic acid and ampicillin (30 and 100 
mg/L, respectively). Transfer of additional resistance genes 
was tested by the disc diffusion method and PCR amplification.
PFGE analysis and MLST
PFGE was performed with the XbaI endonuclease (Thermo 
Fisher Scientific, Waltham, MA, USA), following the 
PulseNet protocol for S. enterica (www.pulsenetinternational.
org). XbaI-digested DNA of S. Braenderup H9812 was used 
as a size marker. The resulting profiles were visually analyzed 
by recording the presence or absence of fragments >33 kb, and 
those with differences in two or more bands were designated 
using serial numbers (eg, X1 and X2). MLST was carried 
out by PCR amplification and sequencing, using the specific 
primers for seven housekeeping genes (aroC, dnaN, hemD, 
hisD, purE, sucA, and thrA) described in the MLST website 
(http://mlst.warwick.ac.uk/mlst/dbs/Senterica). The STs were 
assigned according to the database in the same website.
Hybridization experiments
PFGE and plasmid profiles were transferred into nylon 
membranes (Hybridon™ N+; GE Healthcare Life Sciences, 
Barcelona, Spain) and hybridized with probes for IncFIIA, 
IncFIB, and spvC selected as markers of serovar-specific 
virulence plasmids and for the identified resistance genes 
and integrons [bla
OXA-1-like
, bla
TEM-1-like
, catA1, catA2, aac(3)-
IV, aadB, aadA1-like, strA, strB, sul1, sul2, tet(A), dfrA7, 
dfrA12, and intI1] to establish their location.26 The probes 
were labeled using the PCR DIG labeling mix (Roche Applied 
Science, Barcelona, Spain), followed by gel extraction with 
the GFX™ DNA and Gel Band Purification Kit (GE Health-
care Life Sciences).
Ethical clearance
The strains characterized here were isolated from the ongoing 
invasive bacterial surveillance system that included several 
research protocols reviewed and approved by the Mozambi-
can National Bioethics Committee for Health (IR00002657) 
and by Institutional Review Boards of Hospital Clinic of 
Barcelona, Spain; the US Centers for Disease Control and 
Prevention; and the School of Medicine, University of Mary-
land. Written informed consent was obtained from parents 
or caretakers of the eligible children. 
Results
Serovars and PTs of the bloodstream 
isolates
From blood samples of 25 febrile children admitted to the 
MDH, 36 Salmonella isolates were recovered. Table 1 shows 
the relevant features of the patients, including sex and age, 
risk factors, symptoms and outcome. Fifteen isolates were 
assigned to S. Typhimurium and 21 isolates to S. Enteritidis. 
Both serovars were found in eleven samples, indicating a 
high frequency of mixed infections (Table 1). PT32 and 
U302 (shown by single isolates of S. Typhimurium), and 
PT1 (shown by two isolates of S. Enteritidis) were the only 
recognizable PTs associated with the detected isolates. In 
contrast, seven S. Typhimurium and 16 S. Enteritidis isolates 
displayed five and two RDNC patterns, respectively. The 
remaining isolates were UT (Tables 2 and 3).
Resistance properties of S. Typhimurium
As shown in Table 2, only three of the 15 invasive isolates 
of S. Typhimurium were susceptible to all antimicrobials 
tested. The remaining twelve were MDR, ie, resistant to three, 
five, or six unrelated antimicrobials, including ampicillin 
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(bla
TEM-1
 ± bla
OXA-1
), chloramphenicol (catA1), gentamicin/
kanamycin [aac(3)-IV and aadB], streptomycin (aadA1 ± 
strAB), sulfonamides (sul1 ± sul2), and trimethoprim (dfrA1 
or not identified). Resistance to cephalosporins, nalidixic 
acid, ciprofloxacin, nitrofurantoin, or tetracycline was not 
detected. All MDR isolates carried one or two class 1 inte-
grons, with three different variable regions: 2000 bp/bla
OXA-1
- 
aadA1, 700 bp/aadB, and 1600 bp/dfrA1-aadA1, but class 2 
integrons were not found.
On the basis of plasmid content, the isolates could be 
distributed in three groups, characterized by the presence 
of pSLT (found in susceptible isolates), pSLT-A130-like 
plasmids or pSLT-BT-like plasmids (carried by seven and 
five MDR isolates, respectively; Figure 1A; Table 2). In 
agreement with this, all isolates were positive for the IncFIIA 
and IncFIB replicons and the spvC gene.
All except one of the pSLT-A130-like plasmids had 
a size of about 120 kb. These plasmids were found in S. 
Typhimurium isolates resistant to ampicillin, gentamicin/
kanamycin, streptomycin, sulfonamides, and trimethoprim 
and carried the bla
OXA-1
, bla
TEM-1
, aadA1, and sul1 genes as 
well as the 2000 bp/bla
OXA-1
-aadA1 integron, as demonstrated 
by hybridization experiments of plasmid profiles (Table 2). 
In contrast, aac(3)-IV and the 700 bp/aadB integron, also 
present in these isolates, failed to hybridized with plasmid 
DNA. In a single isolate of the pSLT-A130-like group 
(resistant to ampicillin, streptomycin, and sulfonamides, but 
susceptible to gentamicin/kanamycin and trimethoprim), the 
plasmid was slightly smaller (~115 kb) but carried the same 
resistance genes and the 2000 bp/bla
OXA-1
-aadA1 integron of 
the 120 kb plasmids (Table 2). The pSLT derivatives were 
always accompanied by small ColE1 plasmids (~7 kb), which 
harbored a second copy of the bla
TEM-1
 gene and could be 
transferred into E. coli by transformation. Biparental and 
triparental conjugations, using four representative isolates as 
donors (Table 2), did not yield E. coli transconjugants under 
the applied conditions. This supports that the pSLT-A130-like 
plasmids are neither conjugative nor mobilizable.
pSLT-BT-like plasmids, of about 117 kb, were found 
in five isolates resistant to ampicillin, chloramphenicol, 
Table 1 Features of 25 patients with invasive nontyphoidal salmonellosis and involved serovars
Patient/sex/age Risk factor(s) Symptoms Outcome Sample Isolate(s) Date of 
isolation
1/M/18 months A, M, O Fv, D Discharged MDH 156266,5 MDH-T1, MDH-E1 04/01/2002
2/F/18 months M, SM, S, O Fv Died MDH 160712,1 MDH-T2 28/01/2002
3/M/40 months A, M, O Fv, V Discharged MDH 160836,2 MDH-E3 01/02/2002
4/M/13 months A, SM, M, Fv Discharged MDH 165814,5 MDH-T4 25/02/2002
5/M/9 days – Fv, D Discharged MDH 172089,6 MDH-T5, MDH-E5 18/03/2002
6/unk unk unk unk MDH 173965.8 MDH-E6 08/04/2002
7/M/43 months A, M Fv, D, V Discharged MDH 175838,3 MDH-E7 08/05/2002
8/M/21 months A, O Fv, D, V, Dh Discharged MDH 183027,3 MDH-T8 10/07/2002
9/M/23 months A, SM, S Fv Discharged MDH 183092,1 MDH-T9 10/07/2002
10/F/3 months A, SM, S, O Fv Discharged MDH 193299,2 MDH-T10, MDH-E10 17/09/2002
11/M/14 months A, O Fv Discharged MDH 201596,3 MDH-E11 22/10/2002
12/M/14 months A, M, O Fv Discharged MDH 202045,9 MDH-E12 15/11/2002
13/M/4 months A, SM, S Fv Discharged MDH 202839,8 MDH-E13 10/12/2002
14/F/13 months A, SM Fv Transferred MDH 202944,7 MDH-T14, MDH-E14 10/12/2002
15M/16 months A, SM, S Fv, D, Dh Discharged MDH 213641,6 MDH-T15, MDH-E15 20/01/2003
16/F/19 months A, M Fv, D, V, Dh Died MDH 217168 MDH-E16 10/02/2003
17/M/29 months A, M, S, T/PF Fv, V Discharged MDH 233513,2 MDH-T17, MDH-E17 21/04/2003
18/F/63 months A, SM, S Fv Discharged MDH 233595,8 MDH-E18 22/04/2003
19/M/30 months A, SM, M, O Fv, D, Dh Discharged MDH 233819,9 MDH-T19, MDH-E19 09/05/2003
20/M/15 months A, M, O Fv Left MDH 252510,2 MDH-E20 21/07/2003
21/F/32 months A, O Fv Discharged MDH 252696,1 MDH-T21, MDH-E21 07/08/2003
22/F/15 months – Fv, D Discharged MDH 265314,1 MDH-T22, MDH-E22 07/10/2003
23/F/30 months A, M, O Fv Discharged MDH 265830,6 MDH-E23 03/11/2003
24/F/14 months A, PI, O Fv Left MDH 290256,7 MDH-T24, MDH-E24 11/12/2003
25/M/8 months A, O Fv, D Discharged MDH 282144,3 MDH-T25, MDH-E25 05/01/2004
Notes: Patients are numbered from 1 to 25. Those coinfected with Salmonella enterica serovar Typhimurium and S. enterica serovar Enteritidis are highlighted in bold. Clinical 
diagnosis of typhoid/paratyphoid fever could not be microbiologically confirmed.
Abbreviation: MDH, Manhiça District Hospital; F, female; M, male. A, anemia; SM, severe malnutrition; M, malaria; T/PF, typhoid/paratyphoid fever, S, septicemia; O, other 
(eye disorders; ear disease and mastoiditis; upper respiratory infections; influenza and pneumonia; tuberculosis; protozoal intestinal disease; and other infectious diseases). 
Fv, fever; D, diarrhea; V, vomiting, Dh, dehydration. T, S. enterica serovar Typhimurium; E, S. enterica serovar Enteritidis; unk, unknown.
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streptomycin, sulfonamides, and trimethoprim (Table 2). All 
resistance genes (bla
TEM-1
, catA1, aadA1, strAB, sul1, sul2, 
and dfrA1) as well as the 1600 bp/dfrA1-aadA1 integron 
found in these isolates were mapped on the plasmids. Addi-
tional cryptic plasmids of variable sizes (~84 and 50 kb, of 
undetermined incompatibility group, and ColE1 of ~3 kb) 
were also detected. Although the pSLT-BT-like plasmids 
failed to conjugate through biparental mattings, they could be 
mobilized from representative isolates (Table 2) into E. coli 
by triparental mattings. The obtained transconjugants had the 
same resistance phenotype and genes as the donor isolates.
Resistance properties of S. Enteritidis
With regard to S. Enteritidis (Table 3), only two of 21 invasive 
isolates were susceptible to all antimicrobials tested, while the 
remaining 19 were resistant to five, six, or seven unrelated 
antimicrobials. Resistance to ampicillin (bla
TEM-1
), chlor-
amphenicol (catA2 ± catA1), nalidixic acid (due to a single 
mutation in gyrA, changing TCC/Ser83 to TAC/Tyr, in three 
isolates tested), streptomycin (strAB ± aadA1),  sulfonamides 
(sul1 and sul2), and trimethoprim (dfrA7) was found in all 
MDR isolates, and all except two were also resistant to tet-
racycline [tet(A)]. In contrast, resistance to cephalosporins, 
ciprofloxacin, or nitrofurantoin was not detected. All isolates 
were negative for the integrase gene of class 1 and 2 integrons, 
but positive for the 700 bp/dfrA7 variable region, consistent 
with the presence of a defective class 1 integron.
pSEV was present in the two susceptible isolates, together 
with a small ColE1 plasmid of ~5 kb (Figure 1B; Table 3). 
Larger plasmids, ranging in size from ~95 to 130 kb, were 
found in all MDR isolates, and all except three carried a 
small ColE1 plasmid of about 6 kb. Through hybridization 
experiments, the bla
TEM-1
, catA2, strAB, sul1, sul2, tet(A), 
and dfrA7, and so the defective class 1 integron, were located 
on the larger plasmids. These plasmids also were hybridized 
with probes specific for the IncFIIA and IncFIB replicons, 
and for spvC, identifying them as derivatives of pSEV which, 
according to their resistance properties, appear to be related 
to pUO-SeVR1.9,10,27 Also coinciding with pUO-SeVR1, the 
pSEV derivatives from Mozambique could not be transferred 
Table 2 Characteristics of invasive Salmonella enterica serovar Typhimurium isolates from Mozambique
Patient Isolate PT Resistance 
phenotype (n)
Resistance 
genotype
Class 1 integron Plasmid(s) XP ST
5 MDH-T5 RDNC T3 Susceptible (3) – – pSLT (IncFIIA+IncFIB; 
94 kb)
X1 19
21 MDH-T21 RDNC T4 – – – – X2 19
24 MDH-T24 RDNC T5 – – – – X2 19
1 MDH-T1 RDNC T1 AG/KSSuTp (6) [blaOXA-1-blaTEM-1]-
aac(3)-IV- aadA1-
aadB- sul1-ni
2000 bp/blaOXA-1-
aadA1; 700 bp/aadB
pSLT-A130-like (IncFIIA 
+IncFIB; 120 kb); (ColE1; 
7 kb)
X3 313
4 MDH-T4 RDNC T2 – – – – X3 313
8 MDH-T8 32 – – – – X3 313
10 MDH-T10 UT – – – – X3 313
14 MDH-T14 UT – – – – X3 313
22 MDH-T22 UT – – – – X4 313
2 MDH-T2 RDNC T2 ASSu [blaOXA-1-blaTEM-1]-
aadA1-sul1
2000 bp/blaOXA-1-
aadA1
pSLT-A130-like 
(IncFIIA+IncFIB; 115 kb); 
(ColE1; 7 kb)
X5 313
9 MDH-T9 U302 ACSSuTp (5) blaTEM-1-catA1- 
aadA1-strAB-[sul1-
sul2]-dfrA1
1600 bp/dfrA1-aadA1 pSLT-BT-like 
(IncFIIA+IncFIB; 117 kb); 
(ni; 85 kb); (ColE1; 3 kb)
X6 313
15 MDH-T15 UT – – – pSLT-BT-like 
(IncFIIA+IncFIB; 
117 kb);(ni; 50 kb); 
(ColE1; 3 kb)
X7 313
19 MDH-T19 UT – – – – X7 313
17 MDH-T17 RDNC T2 – – – – X8 313
25 MDH-T25 UT – – – – X8 313
Notes: Patients coinfected with S. enterica serovar Enteritidis are highlighted in bold. Isolates used as donors in biparental and triparental conjugation experiments are 
underlined. Size of the variable region and gene cassette(s) located herein and identified by sequencing. Incompatibility groups; estimated plasmid sizes are shown in 
parentheses. Sequence type determined by multilocus sequence typing.
Abbreviations: MDH, Manhiça District Hospital; n, total number of isolates when more than one; ni, not identified; PT, phage type; RDNC, reacted but did not conform; 
UT, untypeable. A, ampicillin; C, chloramphenicol; G, gentamicin; K, kanamycin; S, streptomycin; Su, sulfonamides; Tp, trimethoprim; XP, XbaI profile. ST, sequence type.
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into E. coli by biparental conjugation. However, 17 of the 21 
pUO-SeVR1-like plasmids could be mobilized through tripa-
rental mattings. The exceptions were the two plasmids lacking 
tet(A). The obtained transconjugants displayed the resistance 
phenotype of the corresponding donor strain and carried all 
resistance genes except catA1, aadA1, and dfrA1, which did 
not alter the resistance phenotype since they are redundant 
with the catA2, strAB, and dfrA7 genes of plasmid origin.
PFGE and MLST analysis of the isolates
Eight XbaI-PFGE profiles were identified among invasive S. 
Typhimurium isolates (Figure 2A), differentially connected 
with susceptible (X1 and X2), pSLT-A130-like (X3, X4, 
and X5), and pSLT-BT-like (X6, X7, and X8) isolates. S. 
Enteritidis isolates showed six profiles (Figure 2B), with X1 
associated with the susceptible isolates and X2–X6 with the 
MDR group. The latter profiles can readily be distinguished 
by a ~350 kb fragment, absent in susceptible isolates from 
Mozambique as well as in the control ATCC 13076. By 
MLST, the three susceptible S. Typhimurium isolates were 
assigned to ST19, while all MDR isolates belonged to ST313. 
In the case of S. Enteritidis, two susceptible and 15 MDR 
isolates were ST11. The remaining four MDR isolates were 
ST1479. 
Discussion
Here we present the resistance properties and molecular types 
of S. Typhimurium and S. Enteritidis isolates  recovered from 
Table 3 Characteristics of invasive Salmonella enterica serovar Enteritidis isolates from Mozambique
Patient Isolate PT Resistance 
phenotype (n)
Resistance genotype Class 1 
integron
Plasmid (s) XP ST
1 MDH-E1 1 Susceptible (2) – – pSEV (IncFIIA+IncFIB; 60 kb)
(ColE1; 5 kb) 
X1 11
10 MDH-E10 1 – – X1 11
3 MDH-E3 RDNC E1 ACSSuTTp (12) blaTEM-1-catA2-strAB-[sul1-
sul2]-tet(A)-dfrA7
700 bp/dfrA7 pUO-SeVR1-like 
(IncFIIA+IncFIB; 95 kb)
(ColE1; 6 kb)
X2 11
5 MDH-E5 RDNC E1 X2 11
6 MDH-E6 RDNC E1 X2 11
14 MDH-E14 RDNC E1 X2 11
16 MDH-E16 UT X2 11
17 MDH-E17 UT X2 11
18 MDH-E18 RDNC E1 X2 11
19 MDH-E19 RDNC E1 X2 1479
21 MDH-E21 UT X2 11
23 MDH-E23 RDNC E2 X2 11
7 MDH-E7 RDNC E1 X3 11
25 MDH-E25 RDNC E1 X4 11
12 MDH-E12 RDNC E2 ACSSuTTp blaTEM-1-catA2-[strAB-
aadA1]-[sul1-sul2]-tet(A)-
dfrA7
700 bp/dfrA7 pUO-SeVR1-like 
(IncFIIA+IncFIB; 95 kb)
X2 1479
15 MDH-E15 RDNC E1 ACSSuTTp blaTEM-1-[catA1-catA2]-
[strAB-aadA1]-[sul1-sul2]-
tet(A)-dfrA1-dfrA7
700 bp/dfrA7 pUO-SeVR1-like 
(IncFIIA+IncFIB; 95 kb)
(ColE1; 6 kb)
X2 11
20 MDH-E20 RDNC E1 ACSSuTp (2) blaTEM-1-catA2-strAB-[sul1-
sul2]-dfrA7
700 bp/dfrA7 pUO-SeVR1-like 
(IncFIIA+IncFIB; 130 kb)
(ColE1; 6 kb)
X5 1479
22 MDH-E22 RDNC E1 X5 11
13 MDH-E13 RDNC E1 ACSSuTTpNal (3) blaTEM-1-catA2-strAB-
[sul1-sul2]-tet(A)-dfrA7-
Ser83Tyr
700 bp/dfrA7 pUO-SeVR1-like 
(IncFIIA+IncFIB; 110 kb)
(ColE1; 6 kb)
X2 11
24 MDH-E24 RDNC E2 pUO-SeVR1-like 
(IncFIIA+IncFIB; 95 kb)
X2 11
11 MDH-E11 RDNC E2 X6 1479
Notes: Patients coinfected with S. enterica serovar Typhimurium are highlighted in bold. Size of the variable region and gene cassette(s) located herein and identified by 
sequencing. Incompatibility group (estimated plasmid size). Sequence type determined by multilocus sequence typing.
Abbreviations: MDH, Manhiça District Hospital; n, total number of isolates when more than one; PT, phage type; RDNC, reacted but did not conform; UT, untypeable. A, 
ampicillin; C, chloramphenicol; Nal, nalidixic acid; S, streptomycin; Su, sulfonamides; T, tetracycline; Tp, trimethoprim; XP, XbaI profile. ST, sequence type.
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blood samples taken from febrile children in rural Mozam-
bique. As previously reported for iNTS, diarrhea, vomiting, 
and dehydration were infrequent, and most children presented 
risk factors, particularly anemia, severe  malnutrition, and/or 
malaria.3 Like in other sub-Saharan countries, HIV  infection 
is a well-recognized risk factor for iNTS in Mozambique, 
being highly prevalent in the population, with a high rate 
of mother-to-child transmission in the community of 
 Manhiça.28–30 Unfortunately, no HIV data were available for 
the study period (2002–2004), since HIV counseling and 
Figure 1 Plasmid profiles of invasive Salmonella Typhimurium and S. Enteritidis isolates from Mozambique. (A) S. Typhimurium. Lanes C1 and C2, plasmids obtained from 
Escherichia coli 39R861 and E. coli V517, used as size standards; lane 1, S. Typhimurium ATCC 14028 (pSLT); lane 2, MDH-T5; lane 3, MDH-T21; lane 4, MDH-T24; lane 5, 
MDH-T1; lane 6, MDH-T4; lane 7, MDH-T8; lane 8, MDH-T10; lane 9, MDH-T14; lane 10, MDH-T22; lane 11, MDH-T2; lane 12, MDH-T8; lane 13, MDH-T15; lane 14, 
MDH-T19; lane 15, MDH-T17; lane 16, MDH-T25. (B) S. Enteritidis. Lanes C1 and C2, size plasmids obtained from E. coli 39R861 and E. coli V517, used as size standards; 
lane 1, S. Enteritidis ATCC 13076 (pSEV); lane 2, MDH-E1; lane 3, MDH-E10; lane 4, CNM4839/03 (pUO-SeVR1); lane 5, MDH-E13; lane 6, MDH-E24; lane 7, MDH-E11; 
lane 8, MDH-E3; lane 9, MDH-E5; lane 10, MDH-E19; lane 11, MDH-E23; lane 12, MDH-E7; lane 13, MDH-E15; lane 14, MDH-E13; lane 15, MDH-E20; lane 16, MDH-E22.
Abbreviation: MDH, Manhiça District Hospital.
C1kb
A B
150
94
65
49.2
37
8
7
5.3
4.6
kb
150
110
65
49.2
37
8
7
5.3
4.6
C2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 C1C2 C1C2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 C1C2
Figure 2 XbaI pulsed-field electrophoresis profiles of invasive Salmonella Typhimurium and S. Enteritidis isolates from Mozambique. (A) S. Typhimurium. Lane B, XbaI-
digested DNA of S. enterica serovar Braenderup H9812, used as size standard; lane C, S. Typhimurium ATCC 14028; lane X1, MDH-T5; lane X2, MDH-T21; lane X3, 
MDH-T4; lane X4, MDH-T22; lane X5, MDH-T2; lane X6, MDH-T9; lane X7, MDH-T15; lane X8, MDH-T17. (B) S. Enteritidis. Lane B, XbaI-digested DNA of S. enterica 
serovar Braenderup H9812, used as size standard; lane C1, S. Enteritidis ATCC 13076; lane C2, CNM4839/03; lane X1, MDH-E1; lanes X2, MDH-E3, MDH-E19; MDH-E12; 
MDH-E15; MDH-E13; MDH-E24; lane X3, MDH-E7; lane X4, MDH-E25; lane X5, MDH-E20; lane X6, MDH-E11. The arrow points the ~350 kb fragment distinctive of MDR 
isolates.
Abbreviations: MDH, Manhiça District Hospital; MDR, multidrug-resistant.
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testing in Manhiça District (southern Mozambique) were 
not established until 2005.
Blood infections with simultaneous detection of two 
Salmonella serovars have rarely been reported and mainly 
concerned S. Typhi and S. Paratyphi A coinfecting Asian 
patients or patients from developed countries who had 
traveled to Asia.31–35 Thus, a surprising result of the present 
study was the high number of patients coinfected with both 
S. Typhimurium and S. Enteritidis. However, a systematic 
assessment of mixed infections was not attempted, so well-
designed comprehensive studies are required to determine 
the actual frequency and impact of coinfections, not only in 
Mozambique, but also in other African countries. Coinfec-
tions could increase the severity of the disease and led to 
treatment failure. The latter is of special relevance in low-
income countries, due to the limited number of cost-effective 
therapeutic alternatives. Nonetheless, the two deaths reported 
in our series were not related with this type of infections.
MDR isolates of S. Typhimurium were ST313 and con-
tained two kinds of pSLT derivatives that probably correspond 
to the pSLT-A130-like and pSLT-BT-like plasmids previously 
reported in lineages I and II of this invasive clone.7,8 Accord-
ing to Okoro et al8, chloramphenicol resistance conferred by 
pSLT-BT-like plasmids together with the use of this antibi-
otic as a drug of choice for the treatment of iNTS in Africa 
could have led to the replacement of lineage I by lineage II, 
which took place around 2003–2005. As indicated above, 
the isolates from Mozambique were collected along the 
period 2002–2004, which overlaps the time proposed for 
the replacement; therefore, temporal coincidence of the two 
kinds of plasmids was to be expected. Interestingly, despite 
being invasive, the three susceptible S. Typhimurium isolates 
belonged to ST19 and carried pSLT.
In contrast to S. Typhimurium, information on the STs of 
invasive S. Enteritidis from African countries is still limited. 
ST11, the most prevalent ST in this serovar, was detected 
in both susceptible and MDR isolates from Mozambique. 
Interestingly, four MDR isolates were assigned to ST1479, an 
uncommon ST that has only been reported in invasive UK iso-
lates from patients linked to Africa.9 All MDR isolates carried 
pSEV derivatives that appear to be related to pUO-SeVR1, like 
those found in the UK isolates, as well as in those belonging 
to the Central/Eastern African clade, which characteristically 
carry the catA2 and tet(A) genes for chloramphenicol and 
tetracycline resistance.9–11,27 Interestingly, XbaI profiles of all 
S. Enteritidis isolates positive for pUO-SeVR1-like plasmids 
that were analyzed thus far included a distinct ~350 kb frag-
ment, absent in susceptible isolates.10,36
Up till now little information exists on the PTs of S. 
Typhimurium and S. Enteritidis causing iNTS in Africa. In 
the present study, most isolates were UT or showed RDNC 
patterns, which did not coincide with any of those previously 
recognized in S. Typhimurium or S. Enteritidis. However, 
data available on PTs mainly were from European countries. 
In Kenya, UT and RDNC isolates have also been recovered 
from patients with gastroenteritis.37 Therefore, distinctive 
PTs appear to be circulating in Africa. PT42, the PT shown 
by invasive UK S. Enteritidis related to Africa,9 was not 
represented among the limited number of isolates tested in 
this study, although it has been reported previously in the 
study community.12
Conclusion
Results of the present study have revealed that 1) serovar- 
specific virulence plasmids were responsible for the MDR 
phenotype of S. Typhimurium and S. Enteritidis recovered from 
febrile children in Mozambique; 2) ST313 (S. Typhimurium), 
ST11, and the uncommon ST1479 (S. Enteritidis), as well as 
previously unrecognized PTs (UT and RDNC) were associ-
ated with these isolates; and 3) nearly half of the children 
were coinfected with both serovars, although there were no 
particularly poor outcomes in the affected patients.
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